CY1112542T1 - Χρηση ενος οιστρογονου για τη βιομηχανικη κατασκευη μιας συνθεσης που περιεχει οιστρογονο για τη θεραπεια ατροφικης κολπιτιδας - Google Patents
Χρηση ενος οιστρογονου για τη βιομηχανικη κατασκευη μιας συνθεσης που περιεχει οιστρογονο για τη θεραπεια ατροφικης κολπιτιδαςInfo
- Publication number
- CY1112542T1 CY1112542T1 CY20121100064T CY121100064T CY1112542T1 CY 1112542 T1 CY1112542 T1 CY 1112542T1 CY 20121100064 T CY20121100064 T CY 20121100064T CY 121100064 T CY121100064 T CY 121100064T CY 1112542 T1 CY1112542 T1 CY 1112542T1
- Authority
- CY
- Cyprus
- Prior art keywords
- estrogen
- treatment
- composition containing
- industrial construction
- atrophic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Χρήση ενός οιστρογόνου στη βιομηχανική κατασκευή μιας σύνθεσης που περιέχει οιστρογόνο για τη θεραπεία ατροφικής κολπίτιδας σε γυναίκες, με χορήγηση εβδομαδιαίως μιας ποσότητας περίπου 10 έως 30 μγραμ. οιστραδιόλης σε μια γυναίκα.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200001890 | 2000-12-15 | ||
DKPA200001891 | 2000-12-15 | ||
DKPA200001892 | 2000-12-15 | ||
EP01270333A EP1343508B1 (en) | 2000-12-15 | 2001-12-13 | Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112542T1 true CY1112542T1 (el) | 2015-12-09 |
Family
ID=27222474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100064T CY1112542T1 (el) | 2000-12-15 | 2012-01-18 | Χρηση ενος οιστρογονου για τη βιομηχανικη κατασκευη μιας συνθεσης που περιεχει οιστρογονο για τη θεραπεια ατροφικης κολπιτιδας |
Country Status (10)
Country | Link |
---|---|
EP (3) | EP3747443A3 (el) |
JP (2) | JP4851057B2 (el) |
AT (1) | ATE532521T1 (el) |
AU (1) | AU2002221567A1 (el) |
CY (1) | CY1112542T1 (el) |
DE (2) | DE10179223T1 (el) |
DK (2) | DK1343508T3 (el) |
ES (2) | ES2725774T1 (el) |
PT (1) | PT1343508E (el) |
WO (1) | WO2002047692A1 (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2725774T1 (es) * | 2000-12-15 | 2019-09-27 | Novo Nordisk Healthcare Ag | Uso de un estrógeno en la fabricación de una composición que contiene estrógeno para el tratamiento de la vaginitis atrófica |
UY29185A1 (es) * | 2004-11-02 | 2006-05-31 | Schering Ag | Formas de dosificación oral sólidas que contienen una dosis baja de estradiol |
EP3272333A1 (en) * | 2016-07-22 | 2018-01-24 | Chemo Research, S.L. | Vaginal composition comprising a combination of estrogen and vitamin d |
EP3603626A1 (en) | 2018-07-31 | 2020-02-05 | Mucosa Innovations, S.L. | Composition for use in the prevention and/or treatment of the genitourinary mucosa |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2739558B1 (fr) * | 1995-10-05 | 1997-11-28 | Innothera Lab Sa | Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale |
AU5181200A (en) * | 1999-06-04 | 2000-12-28 | General Hospital Corporation, The | Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use |
ES2725774T1 (es) * | 2000-12-15 | 2019-09-27 | Novo Nordisk Healthcare Ag | Uso de un estrógeno en la fabricación de una composición que contiene estrógeno para el tratamiento de la vaginitis atrófica |
-
2001
- 2001-12-13 ES ES10179223T patent/ES2725774T1/es active Pending
- 2001-12-13 AU AU2002221567A patent/AU2002221567A1/en not_active Abandoned
- 2001-12-13 EP EP20193530.1A patent/EP3747443A3/en not_active Withdrawn
- 2001-12-13 DE DE10179223.2T patent/DE10179223T1/de active Pending
- 2001-12-13 PT PT01270333T patent/PT1343508E/pt unknown
- 2001-12-13 EP EP10179223A patent/EP2366395A1/en not_active Ceased
- 2001-12-13 AT AT01270333T patent/ATE532521T1/de active
- 2001-12-13 JP JP2002549263A patent/JP4851057B2/ja not_active Expired - Fee Related
- 2001-12-13 DK DK01270333.6T patent/DK1343508T3/da active
- 2001-12-13 DK DK10179223.2T patent/DK2366395T2/da unknown
- 2001-12-13 WO PCT/DK2001/000824 patent/WO2002047692A1/en active Application Filing
- 2001-12-13 EP EP01270333A patent/EP1343508B1/en not_active Revoked
- 2001-12-13 ES ES01270333T patent/ES2376649T3/es not_active Expired - Lifetime
- 2001-12-14 DE DE20120246U patent/DE20120246U1/de not_active Expired - Lifetime
-
2010
- 2010-04-08 JP JP2010089241A patent/JP2010189409A/ja active Pending
-
2012
- 2012-01-18 CY CY20121100064T patent/CY1112542T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2366395A1 (en) | 2011-09-21 |
EP1343508B1 (en) | 2011-11-09 |
DE20120246U1 (de) | 2002-05-29 |
EP3747443A2 (en) | 2020-12-09 |
JP4851057B2 (ja) | 2012-01-11 |
ES2725774T1 (es) | 2019-09-27 |
JP2010189409A (ja) | 2010-09-02 |
ES2376649T3 (es) | 2012-03-15 |
JP2004515531A (ja) | 2004-05-27 |
DK2366395T2 (da) | 2020-06-15 |
EP1343508A1 (en) | 2003-09-17 |
DK2366395T1 (da) | 2019-09-23 |
DE10179223T1 (de) | 2019-10-24 |
EP3747443A3 (en) | 2021-03-03 |
ATE532521T1 (de) | 2011-11-15 |
PT1343508E (pt) | 2012-02-20 |
AU2002221567A1 (en) | 2002-06-24 |
WO2002047692A1 (en) | 2002-06-20 |
DK1343508T3 (da) | 2012-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20060348A (en) | Extended use combination comprising estrogens and progestins | |
NO20032805L (no) | Blandinger med ostrogen-syklodekstrinkomplekser | |
ES2194452T3 (es) | Composiciones antitranspirantes que contienen 1,2-hexanodiol. | |
SE0001899D0 (sv) | New compounds | |
ES2174517T3 (es) | Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas. | |
AP9801169A0 (en) | N-hydroxy-B-sulfonyl propionamide derivatives. | |
DK1157037T3 (da) | GCSF-konjugater | |
BR0105899A (pt) | Agente cosmético pulverulento e processo para a sua preparação | |
ATE391708T1 (de) | Verbindungen und gemische zur verabreichung eines aktiven agens | |
MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
TW200626161A (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
CY1112542T1 (el) | Χρηση ενος οιστρογονου για τη βιομηχανικη κατασκευη μιας συνθεσης που περιεχει οιστρογονο για τη θεραπεια ατροφικης κολπιτιδας | |
BR0107667A (pt) | Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo | |
UA72927C2 (uk) | Композиція для лікування печінково-клітинного раку, що містить доцетаксель | |
IS6654A (is) | Stöðugt gabapentín með pH innan stýrðra marka | |
EP1274414A4 (en) | NASAL ADMINISTRATION OF AGENTS FOR THE TREATMENT OF GASTROPARESE | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
TW200518778A (en) | Shampoo composition | |
EA200301129A1 (ru) | Ингибирование ароматазы для улучшения вспомогательной репродукции | |
DE60202954D1 (de) | Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel | |
UY27376A1 (es) | Formulación de medicamento que contiene un antagonista de ltb4 | |
AR006034A1 (es) | Una composicion antitranspirante, un sistema antitranspirante que la comprende y la utilizacion de un emoliente en la preparacion de la misma | |
ATE251459T1 (de) | Verwendung von dienogest in hoher dosierung | |
EP1322315A4 (en) | FORMULATIONS CONTAINING URSODESOXYCHOLIC ACID FOR REDUCING OR SUPPRESSING TOXICITY OF ENDOCRINE MODULATORS |